To truly discover Rising Stars in a rapidly changing landscape that may no longer recognise traditional metrics – publication numbers, qualifications, involvement in trials, etc – with the
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS